Rare diseases
Investigational molecules
Locations
Back to Germany1 786 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Crofelemer for Adults with Short Bowel Syndrome and Intestinal Failure Without Colon in Continuity
GermanyStudy on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors
GermanyStudy on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions
GermanyStudy on the Effects of Cyclosporine A in Patients with Takotsubo Syndrome
GermanyStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
GermanyStudy of trabectedin alone versus trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
GermanyStudy on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
GermanyStudy on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients
GermanyStudy on the Safety and Effects of STX-241 for Patients with Advanced Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors
GermanyLong-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat
GermanyStudy of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes
GermanyStudy on the Safety and Effectiveness of Teclistamab and Talquetamab for Patients with Newly Diagnosed Multiple Myeloma Eligible for Transplant
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
